Amyris, Inc. Signs Agreement for Up to $60 Million in Funding From Temasek Life Science Ventures Pte Ltd (TLV)
8/8/2013 9:58:55 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
EMERYVILLE, Calif., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, today announced it entered into agreement for the sale of convertible notes in a private placement for up to $60 million in cash proceeds.
Help employers find you! Check out all the jobs and post your resume.